BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Business

  St. Jude Medical Elects Barbara B. Hill to Board of Directors

  December 11, 2007

   · 

  1 min read
• Genetown

  Aspect Medical Systems, Inc. Announces Positive Results of BRITE Major Depression National Study

  December 11, 2007

   · 

  1 min read
• FDA

  Sysmex America, Inc. Receives FDA Clearance for XE-5000(TM) Hematology Analyzer

  December 11, 2007

   · 

  2 min read
• Business

  Anesiva, Inc. (Jobs) and Medical Futures Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Canada

  December 11, 2007

   · 

  5 min read
• Drug Development

  Pharmion Corporation and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study

  December 11, 2007

   · 

  10 min read
• Drug Development

  CuraGen Corporation and TopoTarget A/S Report Belinostat Results Presented at American Society of Hematology and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

  December 11, 2007

   · 

  9 min read
• Rosetta Genomics Ltd. Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008

  December 11, 2007

   · 

  4 min read
• Drug Development

  Trubion Pharmaceuticals Inc. Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin’s Lymphoma

  December 11, 2007

   · 

  4 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

  December 11, 2007

   · 

  8 min read
• Drug Development

  Alexion Pharmaceuticals Inc. Release: PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden

  December 11, 2007

   · 

  10 min read